Read + Share
Amedeo Smart
Independent Medical Education
Embaby A, Kutzera J, Geenen JJ, Pluim D, et al. WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study. Gynecol Oncol 2023;174:239-246.PMID: 37236033
Email
LinkedIn
Facebook
Twitter
Privacy Policy